Our B12 injections use Hydroxocobalamin, a stable form of commercially manufactured Cobalamin (Vitamin B12), which converts easily in the human body to methylcobalamin and Adenosylcobalamin
Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease
People with Type 2 diabetes have a higher risk of heart attacks and strokes GLP-1s may help reduce these risks
doi: 10.1158/1940-6207.CAPR-11-0572
LaiYWangJYueNZhangQWuJQiWet alGlutathione peroxidase-like nanozymes: Mechanism, classification, and bioapplication
Expert Opinion on Biological Therapy , 9 (11), 13471356